CIK 0001659617 · Non-accelerated filer<br>Smaller reporting company
Moleculin Biotech, Inc.
Sign in to watch- Ticker
- MBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474671997
- Phone
- 713-300-5160
- Business address
- 5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-20 | KLEMP WALTER V CEO and President | Option exercise · Restricted Stock Units | −150 | 326,696 | ||
| 2026-06-20 | Foster Jonathan P. Chief Financial Officer | Option exercise | +109 | 12,238 | ||
| 2026-06-20 | Foster Jonathan P. Chief Financial Officer | Shares withheld for taxes | −31 | $2.88 | $89 | 12,207 |
| 2026-06-20 | Foster Jonathan P. Chief Financial Officer | Option exercise · Restricted Stock Units | −109 | 147,892 | ||
| 2025-11-12 | PICKER DONALD H CSO | Grant or award · Stock option (right to buy) | +200,000 | 295,508 | ||
| 2025-11-12 | PICKER DONALD H CSO | Grant or award · Performance Based Restricted Stock Units | +200,000 | 495,508 | ||
| 2025-11-12 | Foster Jonathan P. EVP & CFO | Grant or award · Stock option (right to buy) | +600,000 | 1,617,695 | ||
| 2025-11-12 | Foster Jonathan P. EVP & CFO | Grant or award · Performance Based Restricted Stock Units | +400,000 | 2,017,695 | ||
| 2025-11-12 | KLEMP WALTER V CEO and President | Grant or award · Stock option (right to buy) | +830,000 | 3,210,731 | ||
| 2025-11-12 | KLEMP WALTER V CEO and President | Grant or award · Performance Based Restricted Stock Units | +750,000 | 3,960,731 | ||
| 2025-11-12 | Yan Joy Director | Grant or award · Stock Options (right to buy) | +150,000 | 164,001 | ||
| 2025-11-12 | Cermak Elizabeth Director | Grant or award · Stock Options (right to buy) | +150,000 | 164,668 | ||
| 2025-11-12 | CANNON MICHAEL D Director | Grant or award · Stock Options (right to buy) | +150,000 | 165,336 | ||
| 2025-11-12 | Climaco John M Director | Grant or award · Stock Options (right to buy) | +150,000 | 165,169 | ||
| 2025-11-12 | George Robert E. Director | Grant or award · Stock Options (right to buy) | +150,000 | 165,336 | ||
| 2025-11-04 | PICKER DONALD H Chief Science Officer | Option exercise | +8,750 | 18,902 | ||
| 2025-11-04 | PICKER DONALD H Chief Science Officer | Shares withheld for taxes | −2,131 | $0.50 | $1K | 16,771 |
| 2025-11-04 | PICKER DONALD H Chief Science Officer | Option exercise · Restricted Stock Units | −8,750 | 95,508 | ||
| 2025-11-04 | KLEMP WALTER V CEO and President | Option exercise | +28,750 | 772,357 | ||
| 2025-11-04 | KLEMP WALTER V CEO and President | Shares withheld for taxes | −7,001 | $0.50 | $3K | 765,356 |
Page 3 of 12 · 236 trades